A multicenter collaboration led by the Bellvitge Biomedical Research Institute (IDIBELL) – Institut Català d’Oncologia (ICO) and the Germans Trias i Pujol Research Institute (IGTP) identified a potential new treatment for an aggressive sarcoma arising in the nerves.
The Psychedelics Lobby: Tracking Federal Lobbying by Psychedelics Companies and Nonprofits – Psychedelic Alpha
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture. Subscribe AnnuallySubscribe Monthly Already